Loading clinical trials...
Loading clinical trials...
A Phase IIa Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
Conditions
Interventions
CAN-2409
Valacyclovir
+2 more
Locations
4
United States
City of Hope Medical Center
Duarte, California, United States
The University of Chicago
Chicago, Illinois, United States
The Ohio State University Medical Center, Dept. Neurological Surgery
Columbus, Ohio, United States
The Methodist Hospital Neurological Institute
Houston, Texas, United States
Start Date
March 1, 2007
Primary Completion Date
December 1, 2015
Completion Date
August 1, 2016
Last Updated
April 3, 2024
NCT05099003
NCT02800486
NCT05278208
NCT05839379
NCT00083512
NCT07100730
Lead Sponsor
Candel Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions